Literature DB >> 28821544

When the Damage Is Done: Selecting Patients for Head and Neck Cancer Chemoprevention Trials.

Daniel E Johnson1, Julie E Bauman2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28821544      PMCID： PMC5915371          DOI： 10.1158/1940-6207.CAPR-17-0197

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN： 1940-6215


× No keyword cloud information.
  9 in total

1.  Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase.

Authors:  H Kushida; K Fujita; A Suzuki; M Yamada; T Endo; T Nohmi; T Kamataki
Journal:  Carcinogenesis       Date:  2000-06       Impact factor: 4.944

2.  How much do smoking and alcohol consumption explain socioeconomic inequalities in head and neck cancer risk?

Authors:  A F Boing; J L Ferreira Antunes; M Brasilino de Carvalho; J Francisco de Góis Filho; L P Kowalski; P Michaluart; J Eluf-Neto; P Boffetta; V Wünsch-Filho
Journal:  J Epidemiol Community Health       Date:  2010-08-18       Impact factor: 3.710

3.  Oral Cancer Chemoprevention--The End of EPOC, the Beginning of an Epoch of Molecular Selection.

Authors:  Julie E Bauman; Jennifer Grandis
Journal:  JAMA Oncol       Date:  2016-02       Impact factor: 31.777

Review 4.  Chemoprevention targets for tobacco-related head and neck cancer: past lessons and future directions.

Authors:  Siddharth H Sheth; Daniel E Johnson; Thomas W Kensler; Julie E Bauman
Journal:  Oral Oncol       Date:  2015-04-11       Impact factor: 5.337

5.  Tobacco smoke biomarkers and cancer risk among male smokers in the Shanghai cohort study.

Authors:  Stephen S Hecht; Sharon E Murphy; Irina Stepanov; Heather H Nelson; Jian-Min Yuan
Journal:  Cancer Lett       Date:  2012-07-20       Impact factor: 8.679

Review 6.  Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.

Authors:  Maura L Gillison; Anil K Chaturvedi; William F Anderson; Carole Fakhry
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

7.  Optimized Liquid Chromatography Nanoelectrospray-High-Resolution Tandem Mass Spectrometry Method for the Analysis of 4-Hydroxy-1-(3-pyridyl)-1-butanone-Releasing DNA Adducts in Human Oral Cells.

Authors:  Bin Ma; Chris Ruszczak; Vipin Jain; Samir S Khariwala; Bruce Lindgren; Dorothy K Hatsukami; Irina Stepanov
Journal:  Chem Res Toxicol       Date:  2016-10-12       Impact factor: 3.739

8.  Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.

Authors:  William N William; Vassiliki Papadimitrakopoulou; J Jack Lee; Li Mao; Ezra E W Cohen; Heather Y Lin; Ann M Gillenwater; Jack W Martin; Mark W Lingen; Jay O Boyle; Dong M Shin; Nadarajah Vigneswaran; Nancy Shinn; John V Heymach; Ignacio I Wistuba; Ximing Tang; Edward S Kim; Pierre Saintigny; Elizabeth A Blair; Timothy Meiller; J Silvio Gutkind; Jeffrey Myers; Adel El-Naggar; Scott M Lippman
Journal:  JAMA Oncol       Date:  2016-02       Impact factor: 31.777

9.  Mechanisms of Cancer Induction by Tobacco-Specific NNK and NNN.

Authors:  Jiaping Xue; Suping Yang; Seyha Seng
Journal:  Cancers (Basel)       Date:  2014-05-14       Impact factor: 6.639
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.